SCHEMBL19154290

SCHEMBL19154290

C/N=C/c1cc(Oc2ccc(CO)cc2F)cc(C(F)(F)F)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.36
TTR P02766 1/20 0.34
FFAR1 O14842 2/20 0.33
CYP4F2 P78329 1/20 0.33
CYP4A11 Q02928 1/20 0.33
EPAS1 Q99814 2/20 0.32
S1PR1 P21453 1/20 0.31
S1PR3 Q99500 1/20 0.31
KIF11 P52732 1/20 0.31
RXRA P19793 1/20 0.31
RXRB P28702 1/20 0.31
RXRG P48443 1/20 0.31
PTGS1 P23219 1/20 0.30
PPARD Q03181 2/20 0.30
PPARG P37231 1/20 0.30
PPARA Q07869 1/20 0.30
LMNA P02545 1/20 0.30
MAPT P10636 1/20 0.30
ATM Q13315 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21158175 0.86 TTR (0.40) ARTTRFFAR1CYP4F2CYP4A11
SCHEMBL20667650 0.81 ALDH1A1 (0.36) ARTTREPAS1KIF11L3MBTL1
SCHEMBL14662604 0.80 EPAS1 (0.44) ARTTRFFAR1EPAS1KIF11
SCHEMBL19154082 0.77 ROCK2 (0.41) ARTTRFFAR1CYP4F2CYP4A11
SCHEMBL15904332 0.76 FFAR1 (0.49) ARTTRFFAR1S1PR1S1PR3
SCHEMBL875557 0.75 EPAS1 (0.52) ARTTRFFAR1EPAS1S1PR1
SCHEMBL15813980 0.75 AR (0.45) AREPAS1RXRARXRG
SCHEMBL14661984 0.73 TLR8 (0.40) ARTTRFFAR1EPAS1KIF11
SCHEMBL14662159 0.70 TTR (0.47) ARTTRCYP4F2CYP4A11EPAS1
SCHEMBL14656182 0.70 TTR (0.47) TTRCYP4F2CYP4A11EPAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10428078-B2 Compounds GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2019-10-01 US disclosed
US-20190023715-A1 COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2019-01-24 US disclosed
US-20170204109-A1 Compounds GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2017-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190023715-A1 COMPOUNDS PLAAT2, PLA2G12A, PLA2G1B AR 4494/4885TTR 2416/4885FFAR1 882/4885
US-10428078-B2 Compounds PLAAT2, PLA2G12A, PLA2G1B AR 4494/4885TTR 2416/4885FFAR1 882/4885
US-20170204109-A1 Compounds PLAAT2, PLA2G12A, PLA2G1B AR 4494/4885TTR 2416/4885FFAR1 882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.